CLOV vs CRSP · rev $1.37B vs rev $37.3M
Clover Health Investments Corp (CLOV) versus Crispr Therapeutics AG (CRSP) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Crispr Therapeutics AG (CRSP) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported CRSP revenue for 2024-12-31 was $37.3M. Net income was -$366.3M. Revenue was down 89.9% from 2023-12-31 to 2024-12-31. CRSP currently screens at market cap $5.42B.
CLOV currently screens at market cap $1.55B. CRSP currently screens at market cap $5.42B.
Not investment advice. Open the CLOV and CRSP stock pages for the full models.
Not investment advice.